Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 23Terminated 3Withdrawn 2Recruiting 2Unknown 1No longer available 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Myeloid 1

Conditions

Sarcoma 111Osteosarcoma 41Sarcoma, Ewing 30Rhabdomyosarcoma 28Melanoma 28Neuroblastoma 21Glioblastoma 18Bone Neoplasms 18Rhabdoid Tumor 17Lymphoma, Non-Hodgkin 17Gliosarcoma 16Neoplasms 15Neoplasm Metastasis 15Liposarcoma 15Breast Neoplasms 15Wilms Tumor 14Ovarian Neoplasms 14Glioma 14Medulloblastoma 13Leiomyosarcoma 13Gastrointestinal Stromal Tumors 13Carcinoma, Non-Small-Cell Lung 13Stomach Neoplasms 12Hepatoblastoma 12Colorectal Neoplasms 12Sarcoma, Synovial 11Ependymoma 11Chordoma 11Carcinoma, Renal Cell 11Neurofibrosarcoma 10

Interventions

etoposide phosphate 1Sirolimus 1Etoposide 1Cyclophosphamide 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Pinealoma × Sarcoma × Clear all
NCT02574728 2026-03-02

AflacST1502

Emory University

Phase 2 Active not recruiting
46 enrolled
CNSMyeloidSarcoma

Brain Neoplasms, Carcinoma, Ependymoma, Histiocytosis, Langerhans-Cell, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Pinealoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡